Skip to main content
. 2019 May 1;36(2):157–166. doi: 10.36141/svdld.v36i2.7636

Table 3.

Univariate prognostic models depending on laboratory values, supportive therapies, CAT scan patterns and first absolute cyclophosphamide dosage. Additional plasmapheresis, early cyclophosphamide administration (≤10 days to ILD diagnosis) and an absolute first cyclophosphamide dose ≤800 mg were associated with improved overall survival in ILD patients treated with cyclophosphamide on ICU

graphic file with name SVDLD-36-157-g004.jpg